AtCor Medical product gets US FDA approval
Australia | Regulatory | By BioSpectrum Bureau | 0 Comment | 26 Nov, 2012
Singapore: Australia-based AtCor Medical, the developer and marketer of the SphygmoCor system that noninvasively measure...Read more
CPR to provide access to phase I units in APAC
Australia | News | By BioSpectrum Bureau | 0 Comment | 24 Apr, 2013
Singapore: Australian-based CRO, CPR Pharma Services, is launching a service aimed at US-based companies who want access...Read more
CBio to merge with US firm Inverseon
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2012
Singapore: Australian drug development company CBio will merge with US-based Inverseon in a deal to establish a clinical...Read more
Genentech, startup sign $330 mn deal for cancer targets
Australia | News | By BioSpectrum Bureau | 0 Comment | 28 Jun, 2013
Singapore: Immunocore entered into a research collaboration and licensing agreement with Genentech, a member of the Roch...Read more
China, Australia dominate APAC pharma market
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2012
The pharmaceutical market in several nations of the Asia Pacific (APAC) region witnessed a significant growth during 201...Read more
Spinifex appoints a new chief medical officer
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jun, 2014
Singapore: Spinifex Pharmaceuticals announced that Dr Ronald Marcus would be the new Chief Medical Officer. He would be ...Read more
Celgene halts phase III trial of cancer drug Revlimid
Australia | Regulatory | By BioSpectrum Bureau | 2 Comment | 19 Jul, 2013
Singapore: Celgene has discontinued treatment with Revlimid (lenalidomide), prescribed for for multiple myeloma, in open...Read more
Immune cells essential to establish pregnancy: Study
Australia | News | By BioSpectrum Bureau | 0 Comment | 11 Jul, 2013
Singapore: Research from University of Adelaide have shown that immune cells known as macrophages are critical to fertil...Read more
NZ, Aus govt commit $2.5 mn for rheumatic vaccine
Australia | News | By BioSpectrum Bureau | 0 Comment | 22 Feb, 2013
Singapore: The decision by New Zealand and Australian Prime Ministers to investigate potential vaccines against rheumati...Read more
Australia, China team up to promote healthy ageing
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2012
Singapore: Senior scientists from Australia and China are meeting at the Australian Academy of Science on July 23 and 24...Read more
Aus firm to raise $10 mn for multiple sclerosis drug
Australia | News | By BioSpectrum Bureau | 0 Comment | 27 Nov, 2013
Singapore: Australia medical biotechnology company, Innate Immunotherapeutics, plans to raise up to $10.93 million (A$12...Read more
CardioCel continues to get surgeons' nod in Australia
Australia | News | By BioSpectrum Bureau | 0 Comment | 08 Oct, 2013
Singapore: CardioCel, a cardiovascular tissue patch to repair heart deformities including repairing and reconstructing h...Read more
Aimedics recalls sleep-time glucose monitor HypoMon
Australia | News | By BioSpectrum Bureau | 0 Comment | 05 Aug, 2013
Singapore: Australia-based medical device developer Aimedics, in consultation with Therapeutic Goods Administration (TGA...Read more
Benitec, uniQure sign cross-licensing deal
Australia | News | By BioSpectrum Bureau | 0 Comment | 06 Dec, 2012
Singapore: Benitec Biopharma and uniQure, a leader in the field of human gene therapy, announced a non-exclusive cross...Read more
US patent for Unilife Unifill syringes
Australia | News | By BioSpectrum Bureau | 0 Comment | 10 Jul, 2012
Singapore: The US Patent and Trademark Office (USPTO) has granted Unilife patent for the Unifill ready-to-fill (prefille...Read more
Fujikura to license Cellmid's cancer antibody
Australia | News | By BioSpectrum Bureau | 0 Comment | 23 Jul, 2013
Singapore: Japan-based Fujikura Kasei is going to licence cancer diagnostic antibody midkine (MK) developed by Australia...Read more
Molecular diagnostics is key to future
Australia | Analysis | By BioSpectrum Bureau | 0 Comment | 18 Jun, 2013
China, Japan, India and Singapore are leveraging on genetic technologies to develop molecular diagnostic platform which ...Read more
DSM launches cGMP facility in Brisbane
Australia | News | By BioSpectrum Bureau | 0 Comment | 31 Oct, 2013
Singapore: DSM Pharmaceutical, the custom manufacturing and technology business of Royal DSM, has launched its new cGMP ...Read more